Company Orchestra BioMed Holdings, Inc.

Equities

OBIO

US68572M1062

Advanced Medical Equipment & Technology

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Ratings for Orchestra BioMed Holdings, Inc.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Advanced Medical Equipment & Technology

Delayed Nasdaq Other stock markets 12:03:47 2024-05-13 pm EDT			5-day change	1st Jan Change
4.71 ^USD	0.00%		-10.11%	-48.41%

Apr. 30	Orchestra BioMed Holdings, Inc. Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents	CI
Mar. 27	Orchestra BioMed Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Orchestra BioMed Holdings, Inc. is a biomedical innovation company. Its lead product candidate is BackBeat Cardiac Neuromodulation Therapy (BackBeat CNT) for the treatment of hypertension (HTN), the leading risk factor for death worldwide. It is also developing the Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the leading cause of mortality worldwide. It is developing bioelectronic therapies based on patented CNT technology. BackBeat CNT, also known as Atrioventricular Interval Modulation (AVIM) therapy, is a bioelectronic therapy candidate designed to substantially and persistently lower blood pressure. Virtue SAB is a proprietary drug/device combination product candidate for the treatment of artery disease that is designed to deliver a proprietary, investigational, extended-release formulation of sirolimus (SirolimusEFR) to the vessel wall during balloon angioplasty without the need for balloon coating or a permanent implant.

Number of employees: 56

USD in Million	2022	Weight	2023	Weight	Delta
Medical Device 100.0 %	0	nan %	3	100.0 %	-

USD in Million	2022	Weight	2023	Weight	Delta
United States 100.0 %	0	nan %	3	100.0 %	-

Managers	Title	Age	Since
Darren Sherman FOU	Founder	52	23-01-25
David Hochman CEO	Chief Executive Officer	49	23-01-25
Andrew Taylor DFI	Director of Finance/CFO	53	23-06-05
Hans-Peter Stoll CTO	Chief Tech/Sci/R&D Officer	68	22-03-31
Avi Fischer CTO	Chief Tech/Sci/R&D Officer	-	23-02-06
Yuval Mika CTO	Chief Tech/Sci/R&D Officer	66	23-01-25
Ziv Belsky CTO	Chief Tech/Sci/R&D Officer	55	-
Dennis J. Donohoe CTO	Chief Tech/Sci/R&D Officer	72	-
Kunal Faldu PRN	Corporate Officer/Principal	-	-
George Papandreou PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Eric Rose BRD	Director/Board Member	73	23-01-25
Eric Fain BRD	Director/Board Member	63	23-01-25
David Hochman CEO	Chief Executive Officer	49	23-01-25
Jason Aryeh BRD	Director/Board Member	56	23-01-25
Darren Sherman FOU	Founder	52	23-01-25
Pamela Connealy BRD	Director/Board Member	63	23-01-25

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	35,786,497	21,843,811 ( 61.04 %)	0	61.04 %

Name	Equities	%	Valuation
MEDTRONIC PLC 16.40 %	5,868,916	16.40 %	26 M $
RTW Investments LP 15.71 %	5,620,640	15.71 %	25 M $
HSAC 2 Holdings LLC 12.19 %	4,360,956	12.19 %	19 M $
Perceptive Advisors LLC 6.798 %	2,432,089	6.798 %	11 M $
ABV LLC 5.128 %	1,834,783	5.128 %	8 M $
BlackRock Advisors LLC 3.902 %	1,396,133	3.902 %	6 M $
Vanguard Fiduciary Trust Co. 3.433 %	1,228,347	3.433 %	5 M $
T. Rowe Price International Ltd. 1.740 %	622,608	1.740 %	3 M $
Geode Capital Management LLC 1.190 %	425,749	1.190 %	2 M $
STATE STREET CORPORATION 0.7991 %	285,910	0.7991 %	1 M $

Name	Equities	%	Valuation
MOTUS GI HOLDINGS, INC. 1.03%	53,607	1.03%	4,289 $

Orchestra Biomed Holdings, Inc.

150 Union Square Drive

18938, New Hope

http://www.orchestrabiomed.com

address Orchestra BioMed Holdings, Inc.(OBIO)

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

4.71 USD

Average target price

16.33 USD

Spread / Average Target

+246.78%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
ORCHESTRA BIOMED HOLDINGS, INC.	-48.41%	169M
THERMO FISHER SCIENTIFIC	+11.32%	226B
DANAHER CORPORATION	+9.27%	188B
INTUITIVE SURGICAL, INC.	+13.09%	137B
BOSTON SCIENTIFIC CORPORATION	+25.85%	108B
SIEMENS HEALTHINEERS AG	+0.34%	63.19B
EDWARDS LIFESCIENCES CORPORATION	+11.66%	52.26B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+5.62%	51B
AGILENT TECHNOLOGIES, INC.	+6.74%	43.89B
GE HEALTHCARE TECHNOLOGIES INC.	+5.52%	38.07B

Other Advanced Medical Equipment & Technology